Work

P-219: Relationship between corneal exam findings, best-corrected visual acuity, and ocular symptoms in patients with relapsed or refractory multiple myeloma receiving belantamab mafodotin

Year: 2021

Type: conference-abstract

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/s2152-2650(21)02346-6

Authors: Evangelos Terpos, Ashraf Z. Badros, Rakesh Popat, Paula Rodríguez-Otero, Asim V. Farooq, Bennie Jeng, Simona Degli Esposti, Eric Lewis, Ira Gupta, Joanna Opalinska, Antonio Palumbo, Suzanne Trudel, Vinay Jadhav

Institutions: National and Kapodistrian University of Athens, University of Maryland Medical Center, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, University College London Hospitals NHS Foundation Trust, Clinica Universidad de Navarra, Centro de Investigación Biomédica en Red de Cáncer, Centro de Investigación Médica Aplicada, University of Chicago Medical Center, Moorfields Eye Hospital NHS Foundation Trust, GlaxoSmithKline (United States), GlaxoSmithKline (Switzerland), Princess Margaret Cancer Centre

Language: English

Topic: Drug-Induced Ocular Toxicity

Subfield: Ophthalmology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3212625965

Cites:

Cited by:

Related to: 10